Cardiac cover after bypass or angioplasty — when, with whom, at what loading
Bishan Kumar Agarwal
A post-bypass patient is often told no insurance company will touch them. That's been wrong for at least a decade. The honest answer is: yes, health insurance is available after bypass or angioplasty — but with three conditions in your favour: the right timing, the right documentation, and an application built for the underwriter who will actually read it.
This is not a small distinction. The difference between a decline and an offer on the same patient has, in our experience, almost always come down to how the case was presented — not the case itself.
The 24-month clock
The standard market posture is 24 months of stable post-procedure health before fresh underwriting becomes realistic. This isn't a rule — it's a pattern in how most underwriting teams think about cardiac risk. A procedure that is 26 months old with a clean post-operative record is a very different proposition from one that is 6 months old with limited follow-up data.
If you're inside that 24-month window, the most useful thing you can do is build your documentation. Regular TMT (treadmill stress test) reports, ECHO results with ejection fraction noted, cardiologist follow-up letters, and a current medication list — these are what change the outcome of an application once the window opens.
Ejection fraction (EF) is a particularly important number. An EF of 50% or above is considered normal range; between 40–50% is mildly reduced; below 40% is where underwriters become significantly more cautious. Most successful post-bypass applications we've placed have had an EF of 50% or above at the time of application.
Which insurers actually write post-cardiac
The short answer is: some, not all, and the landscape shifts. Some insurers have written guidelines that make post-cardiac cases near-automatic declines; others have underwriting teams that assess the file on its merits. The companies with the best track record for post-bypass applications are not always the ones with the most-advertised plans.
This is one of those situations where working with someone who tracks current underwriting postures matters more than doing your own research. A company that was placing bypass cases two years ago may have tightened its criteria since; another may have opened up. The file that gets placed is the one sent to the right team at the right time.
We've placed bypass patients with insurers who “don't write cardiac” — three times in 2025. The category “don't write” is mental. The file changes the answer.
What underwriters want to see
Three documents do most of the work: the latest TMT showing normal effort tolerance, the most recent ECHO showing EF at or above 50%, and a cardiologist's stability letter confirming the patient is on a stable regimen and has had no events since the procedure.
Beyond the documents, the full declaration matters. The procedure date, the type of procedure (bypass, stent, valve repair), all current medications, any prior cardiac events before the procedure, smoking history, and family cardiac history — all of it goes into the proposal. An underwriter making a borderline decision will look for the complete picture, and a gap in the declaration is a gap in the story.
Loading for post-bypass cases runs from 25% to 60% depending on EF, time since procedure, lifestyle factors, and the presence of any complications. A 42% loading with ₹10L cover and a 3-year waiting period for cardiac complications is a reasonable outcome for a well-managed case. It is not the end of the insurance story — renewals, and eventually a reduction in loading, are possible as the years of stability accumulate.
What you can't get (and shouldn't try for)
Two things are genuinely off the table in the early post-procedure years. High-cover plans — cover above ₹25L — are typically not available in the first three years after a bypass. The loading makes the premium prohibitive, and most insurers won't offer that sum insured for the risk profile.
The other thing that's off the table: cover for the specific previously-blocked artery or the same event recurring. This is a standard exclusion on post-bypass policies and it is not negotiable. It doesn't mean the policy has no value — hospitalisation for any other cardiac cause, and for all other health conditions, is covered after the waiting period. But go in clear-eyed about what the exclusion means for your specific situation.
Insurance is a contract between you and the insurer. This article is general information only — speak to a licensed advisor about your specific situation before making decisions.
EF below 45%
Ejection fraction below 45% is a significant flag for underwriters — expect steep loading or declines, and consider waiting until your EF stabilises further before applying.
Stent in last 12 months
A stent placed within the past 12 months will typically result in a postponement — most insurers want at least 12 months of post-procedure stability before they'll assess a fresh cardiac application.
Smoking after the procedure
Declare it. Continuing to smoke post-procedure is a material underwriting factor and hiding it creates a future claims risk that far outweighs any loading you might avoid.
Family history of cardiac
First-degree family history of cardiac events is part of the declaration — relevant to both completeness and to the underwriter's overall risk assessment of your file.
58, triple-vessel bypass 2022, EF 55%, on aspirin and statin
58-year-old retired professional. Triple-vessel bypass surgery in 2022. Current EF 55%, on aspirin and atorvastatin, non-smoker, stable for 26 months at time of application.
Applied directly to two insurers in 2024. Both declined — one without explanation, one citing ‘cardiac history.’ No supporting documentation was submitted with either application.
Prepared a structured submission with the cardiologist's stability letter, the 24-month TMT trend (both normal), the most recent ECHO showing EF 55%, and a complete medication list. Approached three insurers with known post-cardiac track records.
Issued by one insurer at 42% loading, ₹10L cover, 3-year waiting period for cardiac complications. The policy excludes the specific previously-blocked artery — standard exclusion for post-bypass cases.
Two declines from direct applications are not a market verdict. They are an application-process verdict. The same file, properly structured and sent to the right underwriter, produced an offer.
Don't take the first ‘no’ as the answer.
If you've been declined after a cardiac procedure, or if you're approaching the 24-month mark and wondering whether to apply — talk to us before you submit anything. The sequence and structure of the application matters.
WhatsApp our team · freeCommon questions.
- How long after my bypass should I wait before applying?
- The standard market posture is 24 months of stable post-procedure health before fresh underwriting becomes realistic. Applying before that window closes usually results in a postponement rather than a considered assessment. Use the waiting period to build your documentation — regular TMT, ECHO reports, and a cardiologist stability letter are what change the outcome.
- What if I've had a stent, not bypass?
- The approach is similar — 12–24 months of post-procedure stability, documented EF, a cardiologist's clearance letter, and a structured proposal. Stent cases are generally viewed a little more leniently than bypass by some underwriters, but the documentation discipline and the waiting period are the same.
- Are there cardiac sub-limits I should watch?
- Yes. Some plans apply specific sub-limits on cardiac procedures — caps on stent costs, bypass hospitalisation, or ICU charges. Read the Schedule of Benefits carefully before choosing a plan, especially the sub-limits section. A plan with a high sum insured but aggressive sub-limits can leave you underinsured for the exact event you are most at risk of.
- Will having a Holter monitor or stress test in my history hurt the application?
- Not in itself — these are diagnostic tools, not diagnoses. What matters is what they found. If the Holter showed a significant arrhythmia or the stress test was abnormal, that finding needs to be in your declaration. The investigation itself is not the problem; an undisclosed finding from the investigation is.